Blood

Aims & Scope

Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.

Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field.

All articles are expected to be concise, well organized and clearly written.

Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.

Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology.

Papers can be listed under more than one category as appropriate.

Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	23.1
2024	21.00

Journal Rank

Year	Value
2024	222

Journal Citation Indicator

Year	Value
2024	19324

SJR (SCImago Journal Rank)

Year	Value
2024	5.823

Quartile

Year	Value
2024	Q1

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

  Citation: 7606

  Authors: Daniel A., Attilio, Robert, Jürgen, Michael J., Michelle M., Clara D., Mario, James W.

• The 2016 revision of the World Health Organization classification of lymphoid neoplasms

  Citation: 6135

  Authors: Steven H., Elias, Stefano A., Nancy Lee, Harald, Reiner, Ranjana, Michele, Gilles A., Andrew D., Elaine S.

• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

  Citation: 4817

  Authors: NL, ES, H, PM, JK, ML, G, C, B, KC

• Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

  Citation: 4615

  Authors: Hartmut, Elihu, David, Sergio, Frederick R., Thomas, Hervé, Benjamin L., Pierre, Richard A., Ross L., Francesco, Tomoki, Dietger, Gert J., Miguel, Jorge, Martin S., Hwei-Fang, Andrew H., Bob, Clara D.

• International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

  Citation: 3667

  Authors: Peter, Christopher, Michelle M., Pierre, Pierre, Guillermo, Miguel, Teresa, Terry, David, Kazuma, Keisuke, Carlo, Ghulam, John

• Human mesenchymal stem cells modulate allogeneic immune cell responses

  Citation: 3601

  Authors: Sudeepta, Mark F.

• Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

  Citation: 3463

  Authors: C. P.

• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

  Citation: 3413

  Authors: James W., Jüergen, Daniel A., Richard D., Michael J., Anna, Nancy Lee, Michelle M., Eva, Ayalew, Clara D.

• Biologic basis for interleukin-1 in disease

  Citation: 3343

  Authors: CA

• WHO-EORTC classification for cutaneous lymphomas

  Citation: 3043

  Authors: R.

---